Publication | Closed Access

Combination of high-dose melphalan and bortezomib as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma

Hematological MalignancyTransplantationMarrow TransplantationOncologyStem Cell TransplantationImmunologyHematologyMultiple MyelomaBlood TransplantationMedicineCell TransplantationHigh-dose Melphalan